Expert Highlights Evolution of Biosimilars in Oncology
Michael Savin, MD, discusses the emergence of biosimilars in oncology, and why there are still obstacles with incorporating them into clinical practice.
Source: OncLive
XPeng (NYSE: XPEV) Unveils Beta Version Navigation Guided Pilot Function




